https://arq197inhibitor.com/pr....ogress-properties-al
We scrutinized the cumulative incidence of long-term MACE (occurring one year post-CA) in patients categorized as either having or lacking ATA recurrence, evaluating this at three time points: 3, 6 months, and 1 year post-index CA. Among the various periods under consideration, we determined the period of recurrence to be the most beneficial predictor of MACE.
Aimer
Commentaire
Partagez
